Excelsior Biopharma (6496) Monthly Revenue

Market: TPEx (OTC) · Industry: Biotech & Medical · 科懋

Excelsior Biopharma (6496) reported revenue of NT$94.8 million for Oct 2026, +32.6% year on year and +24.1% from the previous month. Revenue for Jan–Oct 2026 was NT$775.4 million (+12.3% year on year).

In Oct 2026, it ranked No. 78 by revenue among 160 Biotech & Medical companies.

Monthly revenue chart

Oct 2024 NT$74 million24/10Nov 2024 NT$73.1 millionDec 2024 NT$93.6 millionJan 2025 NT$70.8 millionFeb 2025 NT$60.4 million25/02Mar 2025 NT$78.7 millionApr 2025 NT$66.2 millionMay 2025 NT$72.7 millionJun 2025 NT$63 million25/06Jul 2025 NT$67.5 millionAug 2025 NT$68.5 millionSep 2025 NT$71.2 millionOct 2025 NT$71.5 million25/10Nov 2025 NT$82.1 millionDec 2025 NT$125.6 millionJan 2026 NT$95.6 millionFeb 2026 NT$56.4 million26/02Mar 2026 NT$66 millionApr 2026 NT$85.3 millionMay 2026 NT$77.8 millionJun 2026 NT$69.4 million26/06Jul 2026 NT$88 millionAug 2026 NT$65.8 millionSep 2026 NT$76.4 millionOct 2026 NT$94.8 million26/10

Hover over (or tap) a bar to see that month’s revenue.

Monthly revenue history

MonthRevenueYoYMoM
Oct 2026NT$94.8 million+32.6%+24.1%
Sep 2026NT$76.4 million+7.3%+16.1%
Aug 2026NT$65.8 million-4.0%-25.2%
Jul 2026NT$88 million+30.4%+26.8%
Jun 2026NT$69.4 million+10.1%-10.7%
May 2026NT$77.8 million+6.9%-8.9%
Apr 2026NT$85.3 million+28.9%+29.3%
Mar 2026NT$66 million-16.2%+16.9%
Feb 2026NT$56.4 million-6.6%-41.0%
Jan 2026NT$95.6 million+35.1%-23.9%
Dec 2025NT$125.6 million+34.2%+52.9%
Nov 2025NT$82.1 million+12.3%+14.9%
Oct 2025NT$71.5 million-3.4%+0.4%
Sep 2025NT$71.2 million-4.6%+3.9%
Aug 2025NT$68.5 million-4.7%+1.5%
Jul 2025NT$67.5 million-5.9%+7.0%
Jun 2025NT$63 million-7.4%-13.3%
May 2025NT$72.7 million-5.0%+9.8%
Apr 2025NT$66.2 million-3.0%-15.9%
Mar 2025NT$78.7 million+40.6%+30.3%
Feb 2025NT$60.4 million+27.6%-14.6%
Jan 2025NT$70.8 million-18.5%-24.4%
Dec 2024NT$93.6 million+37.5%+28.0%
Nov 2024NT$73.1 million+1.7%-1.2%
Oct 2024NT$74 million+7.0%-0.8%

Jan–Oct 2026 cumulative: NT$775.4 million (+12.3% YoY)

History covers months since this site began collecting, plus prior-month and prior-year figures in each release. It grows every month.

Other Biotech & Medical companies

Compare with peers: Excelsior Biopharma vs PEC / Excelsior Biopharma vs Lotus Pharm / Excelsior Biopharma vs Bora

CompanyRevenueYoY
PEC6446NT$2.84 billion+102.0%
Lotus Pharm1795NT$2.13 billion-22.5%
Bora6472NT$1.99 billion+15.9%
Great Tree Pharmacy6469NT$1.67 billion+1.5%
EXCELSIOR4104NT$1.02 billion+38.6%
PEGAVISION6491NT$793 million+13.0%
Synmosa Biopharma4114NT$766.6 million+41.2%
Y.S.H.3705NT$749.4 million+4.4%

See also

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16